The architecture of risk for type 2 diabetes: understanding Asia in the context of global findings.
about
Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and PodocytesAddition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 TrialAn estimation of the prevalence of diabetes mellitus and diabetic retinopathy in adults in Timor-Leste.A High Level of Intestinal Alkaline Phosphatase Is Protective Against Type 2 Diabetes Mellitus Irrespective of Obesity.Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo-controlled, double-blind, multicenter trial.PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study.THE DIABETES EPIDEMIC IN CHINA: AN INTEGRATED REVIEW OF NATIONAL SURVEYS.Efficacy and safety of dapagliflozin in Asian patients: A pooled analysis.A Systematic Review: Family Support Integrated with Diabetes Self-Management among Uncontrolled Type II Diabetes Mellitus Patients.Association of PGC-1α gene with type 2 diabetes in three unrelated endogamous groups of North-West India (Punjab): a case-control and meta-analysis study.Correlation of Serum Adiponectin and Leptin levels in Obesity and Type 2 Diabetes Mellitus.
P2860
Q26778527-6A44C327-F64A-4EDC-8675-5049859A92C1Q33614337-E626465C-55FD-4FB1-BDFF-F3A1BA293940Q35666536-E1C3C29D-D9EC-4403-BDA5-1EE35EF5CD53Q36437760-C3813347-707F-480B-B4AA-E57505120D79Q36843902-7DBD43A7-01C7-4EF2-84D0-665067CCED6BQ37735321-38DA3D34-3B21-499C-B195-783A09AFF0AFQ38863419-5191C39D-BF3C-42F1-A7AD-C5F58D2CC3EAQ39393777-F9141014-CABB-498B-A858-68F36DB4155AQ41662899-20F93447-0ED4-4D33-A985-3E8534D8444FQ50075066-A9346931-CAB6-4EB2-B853-0176F9167E0BQ55284990-A1EA1A39-CF44-4CF7-9DF1-B132859F3B19
P2860
The architecture of risk for type 2 diabetes: understanding Asia in the context of global findings.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The architecture of risk for t ...... he context of global findings.
@ast
The architecture of risk for t ...... he context of global findings.
@en
type
label
The architecture of risk for t ...... he context of global findings.
@ast
The architecture of risk for t ...... he context of global findings.
@en
prefLabel
The architecture of risk for t ...... he context of global findings.
@ast
The architecture of risk for t ...... he context of global findings.
@en
P2093
P2860
P356
P1476
The architecture of risk for t ...... he context of global findings.
@en
P2093
Christopher Oldmeadow
Elizabeth G Holliday
John Attia
Rodney J Scott
P2860
P304
P356
10.1155/2014/593982
P577
2014-03-13T00:00:00Z